Table 4.
Effect of different levels of alpha-lipoic acid and ALN on plasma membrane functionality and abnormal forms of rooster thawed semen.
| Parameters | Treatments |
SEM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Control | A10 | A20 | A30 | A40 | A50 | ALN10 | ALN20 | ALN30 | ALN40 | ALN50 | ||
| Membrane integrity (%) | 45.2c,d | 47.2b,c | 51.2b,c | 58.3b | 50.2b,c | 38.7d | 48.1b,c | 57.3b | 69.3a | 52.1b,c | 40.1c,d | 1.9 |
| Abnormal forms (%) | 19.3 | 17.7 | 17.0 | 16.9 | 16.1 | 20.4 | 17.5 | 16.4 | 14.3 | 16.6 | 19.8 | 2.2 |
Different superscripts within the same row indicate significant differences among groups (P < 0.05).
Extender supplemented with different levels of alpha-lipoic acid containing 10 (A10), 20 (A20), 30 (A30), 40 (A40) and 50 (A50) μM and alpha-lipoic acid loaded nanostructured lipid carriers (ALN) containing 10 (ALN10), 20 (ALN20), 30 (ALN30), 40 (ALN40) and 50 (ALN50) μM.